Matkowska-Kocjan, A.; Owoc-Lempach, J.; Ludwikowska, K.; Szenborn, F.; Moskwa, N.; Kurek, K.; Kałwak, K.; Szenborn, L.; Ussowicz, M.
COVID-19 mRNA Vaccine Tolerance and Immunogenicity in Hematopoietic Stem Cell Transplantation Recipients Aged 5–11 Years Old–Non-Randomized Clinical Trial. Vaccines 2023, 11, 195.
https://doi.org/10.3390/vaccines11010195
AMA Style
Matkowska-Kocjan A, Owoc-Lempach J, Ludwikowska K, Szenborn F, Moskwa N, Kurek K, Kałwak K, Szenborn L, Ussowicz M.
COVID-19 mRNA Vaccine Tolerance and Immunogenicity in Hematopoietic Stem Cell Transplantation Recipients Aged 5–11 Years Old–Non-Randomized Clinical Trial. Vaccines. 2023; 11(1):195.
https://doi.org/10.3390/vaccines11010195
Chicago/Turabian Style
Matkowska-Kocjan, Agnieszka, Joanna Owoc-Lempach, Kamila Ludwikowska, Filip Szenborn, Natalia Moskwa, Katarzyna Kurek, Krzysztof Kałwak, Leszek Szenborn, and Marek Ussowicz.
2023. "COVID-19 mRNA Vaccine Tolerance and Immunogenicity in Hematopoietic Stem Cell Transplantation Recipients Aged 5–11 Years Old–Non-Randomized Clinical Trial" Vaccines 11, no. 1: 195.
https://doi.org/10.3390/vaccines11010195
APA Style
Matkowska-Kocjan, A., Owoc-Lempach, J., Ludwikowska, K., Szenborn, F., Moskwa, N., Kurek, K., Kałwak, K., Szenborn, L., & Ussowicz, M.
(2023). COVID-19 mRNA Vaccine Tolerance and Immunogenicity in Hematopoietic Stem Cell Transplantation Recipients Aged 5–11 Years Old–Non-Randomized Clinical Trial. Vaccines, 11(1), 195.
https://doi.org/10.3390/vaccines11010195
